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 Abstract 
 The purpose of this study was to evaluate the associations 
of visfatin and adiponectin concentrations with insulin resis-
tance and body composition in regularly physically active 
pubertal girls. In 129 girls, aged 13 – 15  years (pubertal stages 
3 – 5), visfatin, adiponectin, insulin resistance measured by 
homeostasis model assessment (HOMA), and body compo-
sition measured by dual-energy X-ray absorptiometry were 
evaluated. Visfatin concentration was related to HOMA 
and overall adiposity (body mass index, fat mass) mark-
ers, whereas adiponectin concentration was related to over-
all adiposity (fat mass), central adiposity (trunk fat) and fat 
free mass values. These relationships remained signifi cant 
(p < 0.05) after adjusting for pubertal stage. Visfatin was inde-
pendently related to body mass index ( β = 0.936; p = 0.0001) 
and HOMA ( β = 0.444; p = 0.039) indices, whereas adiponec-
tin was independently related to fat free mass ( β = 0.889; 
p = 0.003) and trunk fat ( β = – 0.468; p = 0.042) values. In con-
clusion, visfatin could be related to insulin resistance and 
overall adiposity indices, whereas adiponectin was related 
to different body composition values in regularly physically 
active pubertal girls. 
 Keywords:  adipokines;  female adolescents;  insulin resis-
tance;  visceral obesity. 
 Introduction 
 Adipose tissue is not merely a site of energy storage but 
also the largest endocrine organ that releases numerous adi-
pokines. Vast evidence suggests that adipokines secreted 
from adipose tissue, such as leptin, tumor necrosis factor- α 
(TNF α ), interleukin-6 (IL-6), and resistin modulate insu-
lin sensitivity and appear to play an important role in the 
development of the metabolic syndrome  (1, 2) . The produc-
tion, release, and plasma concentrations of these adipose 
tissue-derived hormones have been investigated exten-
sively in healthy normal weight  (3, 4) , obese  (1, 5) , and also 
physically active  (6, 7) children and adolescents. Excess 
adiposity, the most common cause of insulin resistance in 
children  (3, 8) , can infl uence the association between these 
adipokines and insulin resistance  (5, 7) . In addition, lower 
levels of adiponectin are related to greater insulin resis-
tance in children and adolescents  (3, 9, 10) . Adiponectin 
is one of the most abundant circulating adipose tissue-spe-
cifi c adipokines, which is mainly produced by adipose tis-
sue  (11) . Because adiponectin appears to respond to acute 
and chronic exercise  (7, 12) , regular physical activity can 
modify the association between adiponectin and insulin 
resistance. Adiponectin has been reported to be higher in 
physically active adolescent females compared to sedentary 
controls  (13) . 
 Visfatin, also known as pre-B cell colony-enhancing fac-
tor, is an adipokine that is also highly expressed in visceral 
adipose tissue  (14) . It has also been suggested that visfatin 
serves as a link between visceral obesity and type 2 diabetes 
mellitus  (15, 16) as visceral obesity is known to be a risk 
factor for the development of insulin resistance and type 
2 diabetes mellitus  (14, 17) . However, other investigators 
have found no difference in the expression of visfatin in vis-
ceral and subcutaneous adipose tissue  (18, 19) . Furthermore, 
Varma et al.  (20) revealed that visfatin is highly expressed 
in subcutaneous adipose tissue in relatively lean and more 
insulin-sensitive subjects. Previous studies of visfatin in 
children and adolescents have provided somewhat con-
fl icting results. A signifi cant positive association between 
plasma visfatin and body mass index (BMI) has been sug-
gested in some studies  (17) , whereas others have reported no 
correlation between visfatin and indices of overall adiposity 
 (1, 3, 15) . In addition, Fernandez-Real et al.  (21) reported 
an independent association between visfatin concentration 
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and insulin resistance in healthy lean adults, whereas previ-
ous studies in children reported no independent relationship 
between visfatin and insulin resistance in physically inac-
tive obese children and adolescents  (1, 3, 15) . However, 
given that insulin sensitivity has been reported to improve 
with chronic exercise training  (22) , it could be postulated 
that visfatin could also be involved in the regulation of insu-
lin sensitivity in regularly physically active adolescents. The 
present study was designed to evaluate the association of 
plasma visfatin concentration with insulin sensitivity and 
body composition variables in regularly physically active 
pubertal girls. In addition, we also examined the relation-
ship between plasma adiponectin, insulin sensitivity, and 
body composition. 
 Methods 
 A total of 129 healthy pubertal girls, aged 13 – 15  years, participated 
in this study. The volunteers were recruited from local training 
groups and had a training history in their selected sports for the past 
2  years  (6) . Pubertal girls had been training for the past 4.6 ± 2.0  years 
with a mean training volume of 6.7 ± 3.5  h/week (Table  1 ). Studied 
girls participated in various sports such as basketball (n = 18), vol-
leyball (n = 15), badminton (n = 14), track and fi eld (n = 22), gymnastics 
(n = 22), swimming (n = 23), and cross-country skiing (n = 15). None of 
the participants took medications or had a history of endocrine, meta-
bolic, or kidney diseases. Throughout the study, no restrictions were 
placed on dietary intake and all subjects consumed their ordinary 
everyday diet  (6) . The study was approved by the Medical Ethics 
Committee of the University of Tartu in Estonia. The purposes, risks, 
and benefi ts were explained to the girls and their parents who signed 
the consent forms. 
 All testing was completed during the two visits of the subjects to 
the laboratory. During the fi rst visit, participants had a fasting 10-mL 
venous blood sample collected. In addition, biological age and main 
anthropometric parameters were assessed. The fi rst measurement 
session was conducted during the early follicular phase of the men-
strual cycle in menstruating girls  (6, 23) . The second measurement 
session consisted of body composition assessment by dual-energy 
 Table 1  Subject characteristics (n = 129). 
Variables Mean ( ± SD) Range
Age, years  14.0 ± 1.0  13 – 15
Pubertal stage (1/2/3/4/5)  4 (3 – 5) 0/0/19/92/18
Years of training  4.6 ± 2.1  2.0 – 8.0
Training duration, h/week  6.7 ± 3.5  3.0 – 16.0
Height, cm 165.5 ± 7.3 149.1 – 186.8
Body mass, kg  54.8 ± 8.9  38.2 – 80.2
BMI, kg/m 2  20.0 ± 2.6  16.8 – 24.6
 % FM  24.5 ± 6.9  11.6 – 42.7
FM, kg  13.2 ± 5.5  4.7 – 21.9
Trunk fat, kg  5.8 ± 2.8  1.7 – 10.5
FFM, kg  41.4 ± 5.3  30.5 – 58.3
Glucose, mmol/L  4.9 ± 0.4  3.7 – 6.1
Insulin,  µ IU/mL  6.3 ± 4.1  2.0 – 23.3
HOMA score  1.37 ± 0.92  0.36 – 4.66
Adiponectin,  µ g/mL  14.6 ± 6.6  0.89 – 33.85
Visfatin, ng/mL  0.9 ± 0.8  0.2 – 4.6
X-ray absorptiometry (DXA). Measurement sessions were separated
by approximately 1  week, dependent on the participant ’ s schedule
and DXA availability.
 Pubertal development of the participants was assessed based on 
self-assessment using an illustrated questionnaire of pubertal stages 
according to the Tanner classifi cation method  (24) . Pubertal devel-
opment assessment according to the Tanner method, which uses 
self-assessment of breasts and pubic hair stage in girls, has been vali-
dated previously  (25) and used in our previous studies with adoles-
cent female subjects  (6) . The girls were given photographs, fi gures 
and descriptions, and asked to choose the one that most accurately 
refl ected their appearance. In case of discrepancies between the two 
variables (breast development and pubic hair stage), greater empha-
sis for the determination of Tanner stage was placed on the degree of 
breast development  (6, 26) . 
 Body height was measured using a Martin metal anthropometer 
to the nearest 0.1  cm with a standardized technique. Body mass 
was measured with minimal clothing to the nearest 0.05  kg using a 
medical electronic scale (A&D Instruments, Abingdon, UK), and 
BMI was calculated as body mass (kg) divided by height (m 2 ). 
Whole-body fat mass (FM) and fat free mass (FFM) were mea-
sured via DXA using the DPX-IQ densitometry (Lunar, Madison, 
WI, USA) equipped with proprietary software, version 3.6. 
Participants were scanned in light clothing while lying supine with 
their arms at their sides. The standard participant positioning was 
used for total body measurements and analyzed using the extended 
analysis option. The standard manufacturer ’ s skeletal landmarks 
were used to defi ne trunk fat. Trunk fat was used as a marker of 
central adiposity  (27) . 
 A 10-mL blood sample was obtained from an antecubital vein with 
the participant sitting in an upright position in the morning (07.00 –
 08.00  h) after an overnight fast. The plasma was separated and frozen 
at  – 20 ° C for later analysis. Blood plasma analysis was completed 
within 6  months after collection. Visfatin and total adiponectin were 
measured with enzyme-linked immunosorbent assay (ELISA) kits 
(AdipoGen and Mediagnost, Aspenhaustr, Germany). The intra- and 
inter-assay coeffi cient of variation (CV) for visfatin was  < 10 % and 
8 % , and for total adiponectin was  < 5 % and 6 % , respectively. Insulin 
was analyzed on an Immulite 2000 (DPC, Los Angeles, CA, USA). 
The intra- and inter-assay CV was  < 5 % and 12 % , respectively, at an 
insulin concentration of 6.6  µ IU/mL. Glucose was measured using 
the hexokinase/glucose-6-phosphate-dehydrogenase method with a 
commercial kit (B ö hringer, Mannheim, Germany). The insulin resis-
tance index from fasting plasma insulin and plasma glucose levels 
was estimated using the homeostasis model assessment (HOMA), 
as follows: fasting plasma insulin ( µ IU/mL) × fasting plasma glucose 
(mmol/L)/22.5  (28) . The greater the HOMA value, the greater was 
the level of insulin resistance. 
 Statistical analysis was performed using SPSS (SPSS Inc., 
Chicago, IL, USA) 15.0 for Windows, and means and standard 
deviations ( ± SD) were calculated. Evaluation of the normality 
was performed with the Shapiro-Wilk statistical test. Log trans-
formation was performed for non-normally distributed variables. 
Relationships of plasma visfatin and adiponectin concentrations 
with other measured variables were assessed by Pearson product 
moment correlation and partial correlation coeffi cient analyses. 
Multiple linear regression analyses were performed using plasma 
visfatin and adiponectin concentrations as the dependent variables 
and using pubertal stage, years of training, BMI, FM, trunk fat, 
FFM, insulin, and HOMA as independent variables. Signifi cance 
was set at p < 0.05. A sample size power calculation indicated that 
129 participants were suffi cient to perform the study with a power 
of 80 % and an  α error of 5 % . 
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 Results 
 The mean ( ± SD), minimum, and maximum values of mea-
sured characteristics for the study population are presented 
in Table  1 . Most of the studied participants were at pubertal 
stage 4 (n = 92), whereas 19 were at pubertal stage 3, and 18 
were at pubertal stages 5, respectively. 
 Plasma visfatin concentration was signifi cantly related 
(p < 0.05) to BMI (r = 0.187; Figure  1 A), FM (r = 0.149), and 
HOMA (r = 0.165; Figure  1 B) values. Partial correlation 
analyses revealed that plasma visfatin concentration was still 
related (p < 0.05) to BMI (r = 0.184), FM (r = 0.154) and HOMA 
(r = 0.158) values after controlling for pubertal stage. There 
was an inverse association (p < 0.05) of plasma adiponectin 
concentration with body mass (r = – 0.170), FM (r = – 0.153), 
and trunk fat (r = – 0.168; Figure  2 A) values in adolescent 
female athletes. In addition, a positive association (p < 0.05) 
between adiponectin and FFM was observed (r = 0.161; Figure 
 2 B). These relationships remained signifi cant (p < 0.05) after 
adjustment for pubertal status for body mass (r = – 0.175), 
trunk fat (r = – 0.155), and FFM (r = 0.151) indices but not for 
FM (r = – 0.115; p > 0.05) value. 
 Using multiple linear regression analysis, visfatin was 
related to BMI ( β = 0.936; p = 0.0001) and HOMA ( β = 0.444; 
p = 0.039) indices, whereas adiponectin was related to FFM 
( β = 0.889; p = 0.003) and trunk fat ( β = – 0.468; p = 0.042) 
values. 
 Discussion 
 In the present study, we investigated whether plasma visfatin 
and adiponectin concentrations are related to specifi c insu-
lin sensitivity and body composition parameters in regularly 
physically active pubertal girls. The results of our inves-
tigation indicated that plasma visfatin concentration was 
positively related to insulin resistance (HOMA) and overall 






































 Figure 1  Relationship of plasma visfatin concentration to body mass index (BMI) (A) (r = 0.19; p < 0.05) and HOMA score (B) (r = 0.17; 
p < 0.05). 










































 Figure 2  Relationship of plasma adiponectin concentration with trunk fat (A) (r = – 0.17; p < 0.05) and fat free mass (FFM) (B) (r = 0.16; 
p < 0.05). 
concentration was negatively related to overall (FM) and 
central (trunk fat) adiposity values, and positively related to 
FFM in regularly physically active adolescent females. To 
our knowledge, this could be the fi rst report to describe the 
plasma visfatin concentrations in regularly physically active 
pubertal girls. Plasma visfatin levels in these girls were simi-
lar and lower than the visfatin concentrations obtained in 
physically inactive normal weight and overweight children 
of similar age  (15) . The adiponectin concentrations in the 
present study were similar to the adiponectin concentrations 
reported in previous studies with regularly physically active 
female adolescents  (13, 29) . In addition, adiponectin concen-
trations have been reported to be higher in physically active 
adolescents in comparison to sedentary adolescents  (13, 29) . 
 The main fi nding of the present investigation was that an 
independent association between circulating visfatin con-
centration and insulin resistance was observed in regularly 
physically active adolescent females. To date, the only pub-
lished studies with visfatin and insulin resistance in children 
also found that visfatin concentrations correlated with insu-
lin and HOMA in heterogeneous groups of obese children 
with both sexes and various pubertal stages  (1, 17) . However, 
a positive relationship between visfatin and HOMA disap-
peared in these children when multivariate analysis was per-
formed  (1, 17) . In support of these fi ndings, Fernandez-Real 
et al.  (21) also reported an independent association between 
visfatin concentration and insulin resistance in healthy non-
obese subjects. However, other studies have found that cir-
culating visfatin levels were not related to insulin resistance 
as assessed by HOMA in different groups of adults with a 
wide range of ages and adiposity values  (19, 30, 31) . Choi 
et al.  (30) reported that 12  weeks of exercise training pro-
gram causing a signifi cant decrease in body mass values 
was accompanied by a signifi cant decrease in visfatin and 
HOMA scores in both normal weight and obese women. By 
contrast, given that insulin sensitivity has been reported to 
improve with exercise training  (22, 30) , the positive asso-
ciation between plasma visfatin and insulin resistance in the 
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regularly physically active adolescent girls studied here sug-
gests that visfatin could be involved in the regulation of insu-
lin sensitivity and a decreased visfatin concentration could 
exert a positive effect on insulin sensitivity in regularly phys-
ically active pubertal girls. Although the role of the visfatin 
gene in lipid metabolism has been suggested, the underly-
ing mechanism is currently unknown  (32) . In addition, some 
studies have reported correlations between visfatin and high-
density lipoprotein cholesterol only in obese adolescents 
and adults  (3, 15, 33) . Accordingly, different adiposity and 
physical activity levels could have a different contribution to 
circulating visfatin concentration. However, further studies 
are needed to ascertain reliable conclusions. 
 It is clear that adipose tissue is not simply a reservoir 
for excess nutrients but an active endocrine organ which 
releases various factors into the circulation. There is increas-
ing evidence of the association between insulin resistance 
and infl ammation involving different cytokines  (14, 31) . 
The importance of these cytokines that infl uence metabolic 
parameters has recently expanded  (14) and the literature 
increasingly implicates these adipose tissue-derived factors 
as major regulators of insulin sensitivity  (2) . Adiponectin 
has been reported to be associated with the indices of insu-
lin resistance in overweight children  (3, 9, 10) and adults 
 (22, 27, 34) . It has been suggested that the protective role 
of adiponectin in insulin resistance is more relevant in over-
weight adolescents, whereas the protective role of adiponec-
tin is minimal in normal weight adolescents  (35) . This could 
at least partially explain why visfatin and not adiponectin in 
the present study was independently related to insulin resis-
tance in regularly physically active pubertal girls ( β = 0.444; 
p = 0.039). The results of the present study indicate that cir-
culating visfatin could have exerted an effect on insulin sen-
sitivity in our specifi c group of regularly physically active 
adolescent females. 
 Positive correlations of plasma visfatin concentrations 
with indices of overall adiposity (BMI, FM) were found in 
this study (r > 0.149; p < 0.05). In addition, BMI was an inde-
pendent variable ( β = 0.936; p = 0.0001) characterizing plasma 
visfatin levels in physically active adolescent females. The 
association between visfatin and BMI is in accordance with 
other studies in children  (17) and adults  (18, 30) . By contrast, 
it has been found that visfatin concentration is not associated 
with BMI in normal weight  (1, 3) and obese  (3, 15) children. 
Likewise, other studies have reported no correlation between 
visfatin and overall adiposity values in adults with a wide 
range of adiposity values  (14, 21, 36, 37) . Furthermore, Araki 
et al.  (1) suggested that plasma visfatin is a surrogate marker 
for visceral fat accumulation in obese children. However, 
other investigations did not fi nd any difference in the expres-
sion of visfatin between subcutaneous and visceral adipose 
tissues  (18, 19) . A possible reason for the confl icting results 
of our study and other studies  (1, 3, 15) could be the fact that 
our subjects were older and more developed in their puber-
tal stage with relatively lean body composition values and 
higher physical activity levels. In addition, discrepancies in 
laboratory measurement methods could also account for these 
differences  (3, 17) . In accordance with a study by Berndt et 
al.  (18) , the results of the present investigation suggest that 
circulating plasma visfatin is associated with overall adipos-
ity values. The reason that no association was found between 
visfatin concentration and trunk fat could be due to the rel-
atively low level of trunk fat in the physically active study 
subjects. However, further interventional studies are neces-
sary to evaluate the relationship of plasma visfatin to different 
adiposity values. 
 In addition to the association between circulating adiponec-
tin and overall adiposity (FM)  (38, 39) in physically active 
adolescent females, measured central adiposity level (trunk 
fat) might also have contributed to plasma adiponectin con-
centration as reported in other studies  (9, 39) . The relation-
ships were similar for measured overall and central adiposity 
indices in regularly physically active adolescent females, 
whereas other studies have indicated that central fat distri-
bution is a better determinant of circulating adiponectin than 
total FM in heterogeneous groups of adolescent children  (9) . 
An interesting fi nding of the present study was that an inde-
pendent association of plasma adiponectin concentration with 
FFM value ( β = 0.889; p = 0.003) was observed in the studied 
pubertal girls. These results imply that in addition to body 
adipose tissue values, other body composition factors such 
as FFM could modulate the plasma adiponectin levels. This 
is consistent with the results of our previous study of middle-
aged premenopausal women, where an independent associa-
tion between adiponectin and FFM values was observed in 
women who had experienced signifi cant alterations in energy 
homeostasis but not in women who had relatively stable body 
mass values  (27) . Indeed, the participants in the present study 
were physically active girls with increased energy expendi-
ture values. However, further studies are needed before any 
conclusions can be drawn. 
 The strength of this study lies in the fact that the study 
population was healthy and regularly physically active ado-
lescent girls who have already reached puberty. To the best 
of our knowledge, this relatively homogeneous group of sub-
jects has not been studied previously. However, we recog-
nize that the selection of this group is not representative of 
the general population of the same age and pubertal devel-
opment. In addition, the cross-sectional nature of our study 
limits determinations of temporality or causality. Therefore, 
further interventional studies are necessary to evaluate the 
relationship of visfatin and adiponectin with different insulin 
resistance and body composition values. Another limitation 
was that the use of a more sensitive measure of insulin resis-
tance than HOMA could strengthen the results of the present 
study. 
 In conclusion, these data support the hypothesis that cir-
culating visfatin could be linked to insulin resistance and 
overall adiposity indices, whereas adiponectin concentration 
is related to different body composition values in a group of 
regularly physically active adolescent females. 
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